{"disease":{"id":"intermittent-explosive-disorder","name":"intermittent explosive disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06118580","title":"Neural Correlates During Alcohol Intoxication","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT06275607","title":"Maladaptive Anger Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The University of Texas at San Antonio","has_results":false},{"nct_id":"NCT06118567","title":"Effect of Nitrous Oxide on Aggression.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT03420222","title":"Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}